Visualitza per autor "Chaparro, María"
Ara mostrant els elements 1-6 d 6
-
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
Garre, Ana; Iborra, Marisa; Sierra-Ausín, Mónica; Barreiro de Acosta, Manuel; Fernández Clotet, Agnès; Monfort Miquel, David; PIQUERAS CANO, MARTA; Chaparro, María (Oxford University Press, 2021-11-08) -
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
Aterido Ballonga, Adria; Guerra, Iván; Cabriada, Jose Luis; Marsal Barril, Sara; Julia Cano, Antonio; Chaparro, María; Bujanda, Luis; Iborra, Marisa (SAGE Publications, 2019-09-25) -
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study
Fernández Salgado, Estela; Robles Alonso, Virginia; Chaparro, María; Baston Rey, Iria; González García, Javier; Ramos, Laura; Diz-Lois Palomares, Mª Teresa (Oxford University Press, 2022-11) -
Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU
Riestra Menéndez, Sabino; Taxonera, Carlos; Zabana, Yamile; Carpio, Daniel; Chaparro, María; Barrio, Jesús; PIQUERAS CANO, MARTA (MDPI, 2022-07-05) -
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab
Baston Rey, Iria; Fernández-Salgado, Estela; González García, Javier; Ramos, Laura; Diz-Lois Palomares, Mª Teresa; Monfort, David; Chaparro, María (MDPI, 2022-08-03) -
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Fernández Salgado, Estela; Robles Alonso, Virginia; Chaparro, María; Baston Rey, Iria; González García, Javier; Ramos, Laura; Diz-Lois Palomares, Mª Teresa (MDPI, 2022-08-03)